CN103550721B - 具有降压安眠功效的中药组合物及含有该组合物的药枕 - Google Patents
具有降压安眠功效的中药组合物及含有该组合物的药枕 Download PDFInfo
- Publication number
- CN103550721B CN103550721B CN201310578830.8A CN201310578830A CN103550721B CN 103550721 B CN103550721 B CN 103550721B CN 201310578830 A CN201310578830 A CN 201310578830A CN 103550721 B CN103550721 B CN 103550721B
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- composition
- chinese medicine
- pillow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 53
- 239000003814 drug Substances 0.000 title claims abstract description 39
- 230000000694 effects Effects 0.000 title claims abstract description 33
- 230000036772 blood pressure Effects 0.000 title claims abstract description 17
- 239000000463 material Substances 0.000 claims description 15
- 239000004753 textile Substances 0.000 claims description 3
- 239000008280 blood Substances 0.000 abstract description 26
- 210000004369 blood Anatomy 0.000 abstract description 26
- 230000001737 promoting effect Effects 0.000 abstract description 13
- 230000017531 blood circulation Effects 0.000 abstract description 12
- 201000010099 disease Diseases 0.000 abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 11
- 244000269722 Thea sinensis Species 0.000 abstract description 9
- 210000000582 semen Anatomy 0.000 abstract description 9
- 238000011282 treatment Methods 0.000 abstract description 7
- 241000628997 Flos Species 0.000 abstract description 6
- 235000009569 green tea Nutrition 0.000 abstract description 6
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 abstract description 6
- 235000012239 silicon dioxide Nutrition 0.000 abstract description 6
- 235000003143 Panax notoginseng Nutrition 0.000 abstract description 5
- 241000180649 Panax notoginseng Species 0.000 abstract description 5
- 210000001161 mammalian embryo Anatomy 0.000 abstract description 5
- 230000000147 hypnotic effect Effects 0.000 abstract description 4
- 230000001360 synchronised effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 10
- 206010020772 Hypertension Diseases 0.000 description 9
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- 230000036407 pain Effects 0.000 description 8
- 208000026435 phlegm Diseases 0.000 description 8
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 7
- 206010022437 insomnia Diseases 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 4
- 208000005171 Dysmenorrhea Diseases 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 210000004209 hair Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 230000000552 rheumatic effect Effects 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 3
- 235000017491 Bambusa tulda Nutrition 0.000 description 3
- 241001330002 Bambuseae Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 239000011425 bamboo Substances 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 210000003026 hypopharynx Anatomy 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 230000035943 smell Effects 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- 241000208686 Eucommiaceae Species 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 244000283207 Indigofera tinctoria Species 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 240000000377 Tussilago farfara Species 0.000 description 2
- 235000004869 Tussilago farfara Nutrition 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 244000237330 gutta percha tree Species 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 241000331777 Arisaema balansae Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 240000005343 Azadirachta indica Species 0.000 description 1
- 229920001342 Bakelite® Polymers 0.000 description 1
- 241001317465 Bambusa textilis Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 241000480045 Citrus suavissima Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 208000007530 Essential hypertension Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 240000002024 Gossypium herbaceum Species 0.000 description 1
- 235000004341 Gossypium herbaceum Nutrition 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241000729196 Lycopus lucidus Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000607292 Maguireothamnus speciosus Species 0.000 description 1
- 235000013500 Melia azadirachta Nutrition 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 241000521581 Millettia Species 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 241000209477 Nymphaeaceae Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000283898 Ovis Species 0.000 description 1
- 241000124463 Paeonia sterniana Species 0.000 description 1
- 241000904014 Pappus Species 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 241000110646 Phryganea japonica Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 239000009759 San-Chi Substances 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- -1 analgesia Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 239000004637 bakelite Substances 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- VQLYBLABXAHUDN-UHFFFAOYSA-N bis(4-fluorophenyl)-methyl-(1,2,4-triazol-1-ylmethyl)silane;methyl n-(1h-benzimidazol-2-yl)carbamate Chemical compound C1=CC=C2NC(NC(=O)OC)=NC2=C1.C=1C=C(F)C=CC=1[Si](C=1C=CC(F)=CC=1)(C)CN1C=NC=N1 VQLYBLABXAHUDN-UHFFFAOYSA-N 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940068204 drug implant Drugs 0.000 description 1
- 239000003844 drug implant Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000005307 ferromagnetism Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- UCNNJGDEJXIUCC-UHFFFAOYSA-L hydroxy(oxo)iron;iron Chemical compound [Fe].O[Fe]=O.O[Fe]=O UCNNJGDEJXIUCC-UHFFFAOYSA-L 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- LIKBJVNGSGBSGK-UHFFFAOYSA-N iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Fe+3].[Fe+3] LIKBJVNGSGBSGK-UHFFFAOYSA-N 0.000 description 1
- YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 229940062054 oxygen 30 % Drugs 0.000 description 1
- 230000024241 parasitism Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 210000001032 spinal nerve Anatomy 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种具有降压安眠功效的中药组合物及含有该组合物的药枕,中药组合物由如下成分组成:当归、代赭石、天门冬、玄参、夜交藤、红花、半夏、天竺黄、天麻、杜仲、丹参、牛膝、远志、何首乌、鸡血藤、莲子芯、磁石、泽兰、栀子、蒲公英、防己、草决明、白芍、瓜蒌皮、陈皮、绿茶、牡丹皮、郁金和三七花。本发明功效显著,具有活血化瘀,疏通经络,降压催眠的功效,通过治疗与睡眠同步的方式,让人在不知不觉中治疗疾病和保持身体健康。
Description
技术领域
本发明属于涉及一种具有降压安眠功效的中药组合物及含有该组合物的药枕。
背景技术
随着人们生活水平的不断提高和工作压力的加大,患有高血压的中老年人越来越多。大多数高血压患者除了高血压症以外,往往伴随有其他病症,如头昏目眩、耳鸣心悸、健忘失眠、偏头痛等症状。因此在治疗和预防高血压的同时,还要对其他并发症和引发症进行治疗和保健,以全方位地缓解病人的痛苦。目前用于治疗这类亚健康综合征状的药物并不多见,并且即使有,部分药物也只针对单一症状进行治疗。而多数的患者难以接受口服类药物进行治疗,往往采用服用保健药物或食品等形式。不管是药物还是保健品、食品等,长期服用都是一种精神负担和经济负担。而人有三分之一的时间是出于睡眠时间,如何利用睡眠时间对生理系统进行治疗是本发明的研究方向。
发明内容
本发明提供一种具有降压安眠功效的中药组合物及含有该组合物的药枕。
所述中药组合物为:由如下重量份数的物质组成:当归90~170份;代赭石105~190份;天门冬90~190份;玄参75~170份;夜交藤90~170份;红花90~185份;半夏70~150份;天竺黄105~200份;天麻85~200份;杜仲105~210份;丹参85~230份;牛膝100~220份;远志130~270份;何首乌80~200份;鸡血藤90~230份;莲子芯85~190份;磁石100~270份;泽兰90~280份;栀子85~180份;蒲公英60~190份;防己70~150份;草决明70~190份;白芍80~200份;瓜蒌皮100~190份;陈皮90~190份;绿茶80~200份;牡丹皮90~180份;郁金90~190份,三七花160~220份。
优选的,所述中药组合物为:由如下重量份数的物质组成:当归100~160份;代赭石120~180份;天门冬100~180份;玄参90~150份;夜交藤100~160份;红花100~170份;半夏80~140份;天竺黄120~200份;天麻100~180份;杜仲110~200份;丹参100~220份;牛膝120~200份;远志150~260份;何首乌90~180份;鸡血藤110~200份;莲子芯100~180份;磁石110~250份;泽兰100~260份;栀子100~160份;蒲公英80~180份;防己80~140份;草决明80~170份;白芍100~190份;瓜蒌皮110~180份;陈皮100~170份;绿茶100~180份;牡丹皮100~170份;郁金100~180份,三七花180~200份。
最优选的,所述中药组合物为:由如下重量份数的物质组成:当归 150份;代赭石170份;天门冬150份;玄参150份;夜交藤150份;红花155份;半夏130份;天竺黄170份;天麻150份;杜仲150份;丹参160份;牛膝160份;远志190份;何首乌130份;鸡血藤150份;莲子芯150份;磁石160份;泽兰190份;栀子140份;蒲公英140份;防己120份;草决明140份;白芍150份;瓜蒌皮150份;陈皮150份;绿茶150份;牡丹皮145份;郁金150份,三七花190份。
其中成分中所涉及的当归,别名干归、马尾当归、秦哪、马尾归、云归、西当归、岷当归、金当归、当归身、涵归尾、土当归多年生草本植物,主治血虚诸证;月经不调;经闭;痛经;症瘕结聚;崩漏;虚寒腹痛;痿痹;肌肤麻木;肠燥便难;赤痢后重;痈疽疮疡;跌扑损伤。
其中成分中所涉及的代赭石,又名须丸、赤土、丁头代赭、血师、紫朱、赭石、土朱、铁朱、钉头赭石、钉赭石、赤赭石、红石头、代赭,为氧化物类矿物赤铁矿的矿石;主含三氧化二铁(Fe2O3),其中铁70%,氧30%,并含有硅、铝、钛、镁、锰、钙、铅、砷等杂质。主治功能:平肝镇逆,凉血止血。治噫气呕逆,噎膈反胃,哮喘,惊痫,吐血,鼻衄,肠风,痔瘘,崩漏带下。
成分中所涉及的天门冬,又名天冬。性寒,味甘,微苦。具有养阴清热,润肺滋肾的功效。用于治阴虚发热、咳嗽吐血、肺痈、咽喉肿痛、消渴、便秘等病症。
成分中所涉及的玄参,主治:温热病和营血、身热、烦渴、舌绛、发斑、骨蒸劳嗽、虚烦不寤、津伤便秘、目涩昏花、咽喉肿痛、瘰疬痰核、痈疽疮毒。
成分中所涉及的夜交藤,属于多年生草本。块根肥厚,长椭圆形,黑褐色。茎缠绕,长2-4米,托叶鞘膜质,偏斜,无毛,花期8-9月,果期9-10月。主治:治失眠症,劳伤,多汗,血虚身痛,痈疽,瘰疬,风疮疥癣;夜交藤性平无毒,味甘微苦,入心、肝经,有安神养血、祛风通络的功效,主治阴虚血少、虚烦不眠、风湿痹痛、皮肤痒疹等症。
成分中所涉及的红花,又称草红花。双子叶植物,菊科,干燥的管状花,长约1.5厘米,橙红色,花管狭细,先端5裂,裂片狭线形,长5~7毫米,雄蕊5枚,花药黄色,联合成管,高出裂片之外,其中央有柱头露出。具特异香气,味微苦。以花片长、色鲜红、质柔软者为佳。主产河南、湖南、浙江、四川等地。活血通经,去瘀止痛,可治疗跌打损伤。
成分中所涉及的半夏,天南星科药用植物,药用部位为块茎。于夏、秋两季茎叶茂盛时采挖,除去外皮及须根,晒干或烘干,即为生半夏。因其毒性较大,多炮制后使用,依炮制方法不同分法半夏、姜半夏、清半夏等。其味辛,性温,有毒;归脾、胃、肺经。功能燥湿化痰,和中健胃,降逆止呕,消痞散结,外用可消肿止痛。
成分中所涉及的天竺黄,禾本科植物青皮竹等因被寄生的天竺黄蜂咬洞后,而于竹节间贮积的伤流液,经干涸凝结而成的块状物质。冬季采收,砍取竹秆,剖取天竺黄,晾干。本品自然产出者很少,大多采用火烧竹林的方法,使竹受暴热后,竹沥溢在节间凝固而成,然后剖取晾干。主产云南、广东、广西等地。具有祛风除湿,活血舒经,止咳的功效。用于风湿痹痛,四肢麻木,小儿百日咳,白带过多。有谓尚可治胃病。具有清热豁痰,凉心定惊的功效。
成分中所涉及的天麻,为多年生草本植物,分布于全国大部分地区。其干燥块茎亦称天麻,是一味常用而较名贵的中药,临床多用于头痛眩晕、肢体麻木、小儿惊风、癫痫、抽搐、破伤风等症。天麻的功能主要可以平肝息风、祛风止痛。天麻适合由内风所导致的头晕,但其对感冒所引起的头痛头晕并不适合。天麻还有镇静、镇痛的作用,可以增加脑血流量,降低脑血管的阻力,较轻微的收缩脑血管等功效,能降低血压,减缓心律,对心肌缺血起到保护的作用。所以,天麻对治脑血栓有一定效果,但并不起到决定性作用。天麻润而不燥,主入肝经,长于平肝息风,凡肝风内动、头目眩晕之症,不论虚实,均为要药。
成分中所涉及的杜仲,又名胶木,为杜仲科植物。杜仲,别名杜仲、丝楝树皮、丝棉皮、棉树皮、胶树,拉丁文名Eucommia ulmoides.为杜仲科植物杜仲(Eucommia ulmoides Oliver)的干燥树皮,是中国名贵滋补药材。以杜仲叶为原料的杜仲茶具补肝肾、强筋骨、降血压、安胎等诸多功效。杜仲性温,味甘,具有补肝肾、壮腰膝、强筋骨、安胎的功效。杜仲对免疫系统、内分泌系统、中枢神经系统、循环系统和泌尿系统都有不同程度的调节作用,杜仲能兴奋垂体-肾上腺皮质系统,增强肾上腺皮质功能。
成分中所涉及的丹参,又名赤参,紫丹参,红根等。为双子叶植物唇形科,干燥根及根茎。性微寒,具有活血化瘀、养血安神功能,现代研究证明可使微循环血流显著加快,毛细血管网开放数增多,可改变血液流变性异常,临床应用故对高血压引起的失眠具有较好效果。
成分中所涉及的牛膝,主治腰膝酸痛;下肢痿软;血滞经闭;痛经;产后血瘀腹痛;症瘕;胞衣不下;热淋;血淋;跌打损伤;痈肿恶疮;咽喉肿痛。具有祛风药、活血祛瘀之功效。
成分中所涉及的远志,性温,味苦、辛,具有安神益智、祛痰、消肿的功能,用于心肾不交引起的失眠多梦、健忘惊悸,神志恍惚,咳痰不爽,疮疡肿毒,乳房肿痛。
成分中所涉及的何首乌,中药何首乌有生首乌与制首乌之分:生首乌功能解毒(截疟)、润肠通便、消痈;制首乌功能补益精血、乌须发、强筋骨、补肝肾。
成分中所涉及的鸡血藤,是豆科崖豆藤属的植物,主治活血舒筋;养血 调经。主手足麻木;肢体瘫痪;风湿痹痛;妇女有经不调;痛经;闭经,具有补血,活血之功效。
成分中所涉及的莲子芯,属睡莲科植物莲的成熟种子中的干燥幼叶及胚根,性寒、味苦、无毒,具有清心去热、涩精、止血、止咳等功效,可治疗心衰、休克、阳萎、心烦、口渴、吐血、遗精、目赤、肿痛等病症。
成分中所涉及的磁石,为氧化物类矿物磁铁矿的矿石。形态:等轴晶系。晶体呈八面体、十二面体。晶面有条纹。多为粒块状集合体。铁黑色,或具暗蓝靛色。条痕黑,半金属光泽。不透明。无解理。断口不平坦。硬度5.5~6.5。密度5.16~5.18g/cm3。具强磁性。性脆。无臭,无味。主治主眩晕;目花;耳聋;耳鸣;惊悸;失眠,肾虚喘逆,具有平肝潜阳;安神镇惊;聪耳明目;纳气平喘之功效。
成分中所涉及的泽兰,别名地瓜儿苗、地笋、地石蚕、蛇王草,主治活血化瘀,行水消肿。用于月经不调、经闭、痛经、产后瘀血腹痛、水肿。具有活血化瘀,行水消肿之功效。
成分中所涉及的栀子,别名黄栀子、山栀、白蟾,是茜草科植物栀子的果实。目前,栀子的果实是传统中药,属卫生部颁布的第l批药食两用资源,具有护肝、利胆、降压、镇静、止血、消肿等作用。在中医临床常用于治疗黄疸型肝炎、扭挫伤、高血压、糖尿病等症。
成分中所涉及的蒲公英,属菊科多年生草本植物。头状花序,种子上有白色冠毛结成的绒球,花开后随风飘到新的地方孕育新生命。蒲公英植物体中含有蒲公英醇、蒲公英素、胆碱、有机酸、菊糖等多种健康营养成分,有利尿、缓泻、退黄疸、利胆等功效。蒲公英同时含有蛋白质、脂肪、碳水化合物、微量元素及维生素等,有丰富的营养价值,可生吃、炒食、做汤,是药食兼用的植物。
成分中所涉及的防己,主治水肿脚气,小便不利,湿疹疮毒,风湿痹痛,高血压症,具有利水消肿,祛风止痛之功效。
成分中所涉及的草决明,也叫草决明、羊明、羊角、马蹄决明、还瞳子、狗屎豆、假绿豆、马蹄子、千里光、芹决、羊角豆、野青豆、猪骨明、猪屎蓝豆、细叶猪屎豆、夜拉子、羊尾豆。味苦、甘而性凉,具有清肝火、祛风湿、益肾明目等功能。
成分中所涉及的白芍,也称白花芍药,是毛茛科芍药属植物,白芍性凉,味苦酸,微寒,具有补血柔肝、平肝止痛。敛阴收汗等功效。
成分中所涉及的瓜蒌皮,主治润肺化痰,利气宽胸。治痰热咳嗽,咽痛,胸痛,吐血,衄血,消渴,便秘,痈疮肿毒。
成分中所涉及的陈皮,别名:橘皮、贵老、红皮、黄橘皮、广橘皮、新会皮、柑皮、广陈皮。主治理气健脾,燥湿化痰。
成分中所涉及的绿茶,是指采取茶树新叶,未经发酵,经杀青、揉拧、 干燥等典型工艺,其制成品的色泽,冲泡后茶汤较多的保存了鲜茶叶的绿色主调。常饮绿茶能防癌,降血脂和减肥,仅具有提神清心、清热解暑、消食化痰、去腻减肥、清心除烦、解毒醒酒、生津止渴、降火明目、止痢除湿等药理作用,还对现代疾病,如辐射病、心脑血管病、癌症等疾病,有一定的药理功效。茶叶具有药理作用的主要成份是茶多酚、咖啡碱、脂多糖、茶氨酸等。
成分中所涉及的牡丹皮,所含牡丹酚及其以外的糖苷类成分均有抗炎作用;牡丹皮的甲醇提取物有抑制血小板作用;牡丹酚有镇静、降温、解热、镇痛、解痉等中枢抑制作用及抗动脉粥样硬化、利尿、抗溃疡等作用。
成分中所涉及的郁金,郁金,味辛、苦,性寒。归肝、心、肺经,具有行气化瘀、清心解郁、利胆退黄、活血止痛、行气解郁、清心凉血之用。
成分中所涉及的三七花,性凉、味甘微苦,具有清平肝热、镇静安神之功,现代药理研究三七花总皂甙对中枢神经系统呈抑制作用,对周围血管有扩张作用。
发明人不断探索具有针对原发性高血压引起失眠的病因病机特点,以中医辨证施治筛选的一组中药组方,其性味辛凉、芳香清透,具有镇静、安神之功。
本发明还涉及一种具有该中药组合物的降压催眠药枕,包括枕体,所述枕体包括外套和枕芯,所述枕体的四个角上均具有矩形撑架体,所述外套和所述枕芯均与所述矩形撑架体相连,所述枕芯内填充所述中药组合物,每个所述矩形撑架体上均具有开孔,所述开孔与所述枕芯内部连通,所述开孔上具有网罩。
所述撑架体上具有覆盖于所述网罩外表面的滑动拨片,将所述滑动拨片拨开则所述网罩露出。
所述滑动拨片外表面具有拨片柄。
所述外套为透气性材料制成,所述枕芯为非透气材料制成。
所述外套为纯棉材料制成。
本发明具有的优点和积极效果是:该降压催眠枕的作用:一是通过鼻腔闻到中药特有的清凉芳香气味,达到“闻香除病”之功,二是中药的有效成份通过颈部的皮肤进入体内(同时该部位也正是华佗夹脊之穴,穴下有椎骨下发出的脊神经后支及伴行的动、静脉分布);人每天要有三分之一的时间在枕头上度过,通过头颈部温度能使枕内药物有效成份以微粒子形式进入体内,对神经和微循环系统达到调节,使经络通畅,阴阳平衡,使血压降低睡眠增加。
附图说明
图1是本发明的整体结构示意图;
图2是A向剖视示意图;
图3是撑架体放大示意图;
图4是撑架体上滑动拨片结构放大示意图;
图中:1为枕体;2为矩形撑架体;21为开孔;211为滑动拨片;212为网罩;213为拨片柄;3为外套层;4为枕芯外层;5为中药材填充物。
具体实施方式
针对于本发明中中药组合物的具体配方给出六个具体实施例,如下表:
制备方法:将各实施例的组分,研细末后装入降压药枕的枕芯之中,其中降压催眠药枕结构为:如图所示,包括枕体,枕体包括外套和枕芯,枕体的四个角上均具有矩形撑架体2,外套和枕芯均与矩形撑架体2相连,枕芯内填充中药,每个矩形撑架体2上均具有开孔21,开孔21与枕芯内部连通,开孔21上具有网罩212。
中药为降压催眠功效的中药。
撑架体2上具有覆盖于网罩212外表面的滑动拨片211,将滑动拨片211拨开则网罩212露出。当滑动拨片211完全覆盖于网罩212上时,枕芯内的气味无法释放出来,这样就可以在不使用时避免气味挥发造成的浪费,无形中延长了降压催眠枕的使用寿命;使用时,只需拨开滑动拨片211将网罩212暴露出来即可使药味散发,达到调养的目的,还可根据需要调整网罩212暴露的多少,这样可以调节气味散发的浓度,满足不同人群的需要。
滑动拨片211外表面具有拨片柄213。拨片柄213使滑动拨片211易于拨动。
外套为透气性材料制成,枕芯为非透气材料制成。这样使枕芯中的药气仅能通过开孔21散出,保证气味浓度可调节的同时避免了药材的浪费。
外套为纯棉材料制成,避免过敏现象的发生。
本发明应在干燥的条件下保存,其有效期为260天。
发明人为了验证含有该中药组合物的药枕的质量功效进行了大量的临 床试验:其中针对每一个实施例均选择50位高血压患者,其中,25位轻度高血压患者和25位中度高血压、失眠患者,疗程为一个月,通过给这50位患者使用降压催眠枕来进行临床研究,结果如下表:
从上表数据可以看出,本发明的具有中药组合物的药枕对于中度轻度高血压患者具有明显的降压效果,对于睡眠状况的改善效果也相当显著。
以上对本发明的多个实施例进行了详细说明,但所述内容仅为本发明的较佳实施例,不能被认为用于限定本发明的实施范围。凡依本发明申请范围所作的均等变化与改进等,均应仍归属于本发明的专利涵盖范围之内。
Claims (7)
1.一种具有降压安眠功效的药枕,其特征在于:包括枕体(1),所述枕体(1)包括外套和枕芯,所述枕体(1)的四个角上均具有矩形撑架体(2),所述外套和所述枕芯均与所述矩形撑架体(2)相连,所述枕芯内填充所述中药组合物,每个所述矩形撑架体(2)上均具有开孔(21),所述开孔(21)与所述枕芯内部连通,所述开孔(21)上具有网罩(212),所述枕芯内填充的所述中药组合物由如下重量份数的物质组成:
2.根据权利要求1所述的药枕,其特征在于:所述中药组合物由如下重量份数的物质组成:
3.根据权利要求2所述的药枕,其特征在于:所述中药组合物由如下重量份数的物质组成:
4.根据权利要求1所述的药枕,其特征在于:所述撑架体(2)上具有覆盖于所述网罩(212)外表面的滑动拨片(211),将所述滑动拨片(211)拨开则所述网罩(212)露出。
5.根据权利要求4所述的药枕,其特征在于:所述滑动拨片(211)外表面具有拨片柄(213)。
6.根据权利要求1-5中任一项所述的药枕,其特征在于:所述外套为透气性材料制成,所述枕芯为非透气材料制成。
7.根据权利要求6所述的药枕,其特征在于:所述外套为纯棉材料制成。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310578830.8A CN103550721B (zh) | 2013-11-14 | 2013-11-14 | 具有降压安眠功效的中药组合物及含有该组合物的药枕 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310578830.8A CN103550721B (zh) | 2013-11-14 | 2013-11-14 | 具有降压安眠功效的中药组合物及含有该组合物的药枕 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103550721A CN103550721A (zh) | 2014-02-05 |
| CN103550721B true CN103550721B (zh) | 2015-08-26 |
Family
ID=50005194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310578830.8A Expired - Fee Related CN103550721B (zh) | 2013-11-14 | 2013-11-14 | 具有降压安眠功效的中药组合物及含有该组合物的药枕 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103550721B (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105193184A (zh) * | 2015-09-21 | 2015-12-30 | 董春年 | 一种降压中药枕及其制备方法 |
| CN105768738A (zh) * | 2016-03-07 | 2016-07-20 | 宁波高新区苗姑养生科技有限公司 | 一种防治心脾痰热型睡眠障碍症的保健枕 |
| CN107467993A (zh) * | 2016-06-07 | 2017-12-15 | 郭敖勇 | 一种保健药枕 |
| CN107772956A (zh) * | 2017-12-04 | 2018-03-09 | 聂清江 | 一种增强老年人体质的中药枕 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1074612A (zh) * | 1993-01-09 | 1993-07-28 | 李继田 | 一种治疗高血压病的药物 |
| CN101406672A (zh) * | 2008-11-16 | 2009-04-15 | 路敦祥 | 治疗高血压的中药药酒及其制备方法 |
| CN102318989A (zh) * | 2010-05-18 | 2012-01-18 | 董建军 | 降压枕 |
| CN102652637A (zh) * | 2011-03-02 | 2012-09-05 | 张意立 | 一种助睡眠保健药枕 |
-
2013
- 2013-11-14 CN CN201310578830.8A patent/CN103550721B/zh not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1074612A (zh) * | 1993-01-09 | 1993-07-28 | 李继田 | 一种治疗高血压病的药物 |
| CN101406672A (zh) * | 2008-11-16 | 2009-04-15 | 路敦祥 | 治疗高血压的中药药酒及其制备方法 |
| CN102318989A (zh) * | 2010-05-18 | 2012-01-18 | 董建军 | 降压枕 |
| CN102652637A (zh) * | 2011-03-02 | 2012-09-05 | 张意立 | 一种助睡眠保健药枕 |
Non-Patent Citations (1)
| Title |
|---|
| 中药治疗高血压的用药规律探要;屠庆祝 等;《实用中医内科杂志》;20051231;第19卷(第01期);84-85 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103550721A (zh) | 2014-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103005106B (zh) | 一种抗衰提高免疫力的茶饮及其制备方法 | |
| CN103610978B (zh) | 一种治疗失眠的药物及其制备方法 | |
| CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
| CN106310120A (zh) | 一种广普型中药组合物水剂及其制备方法 | |
| CN103860969A (zh) | 一种增肥的中药 | |
| CN103550721B (zh) | 具有降压安眠功效的中药组合物及含有该组合物的药枕 | |
| CN103394058B (zh) | 一种治疗产后风的药物及其制备方法 | |
| CN105232911A (zh) | 一种中药组合物 | |
| CN102579708A (zh) | 一种壮阳补肾健肝肺的中药配方 | |
| CN104825855A (zh) | 一种抗衰老中药组合物及制备方法 | |
| CN104623384A (zh) | 乳腺增生疏肝理气药物及制备方法 | |
| CN103550694A (zh) | 一种治疗脱发的药物及其制备方法 | |
| CN102293964B (zh) | 一种治疗胃溃疡的药物及其制备方法 | |
| CN105343593A (zh) | 一种降压降脂的夏枯草保健口服液及其制备方法 | |
| CN104127663A (zh) | 一种治疗阴虚火旺型经行失眠的中成药 | |
| CN103656197B (zh) | 补肾补血的中药组合物及制备方法 | |
| CN104689283A (zh) | 一种治疗脾虚湿蕴型黄褐斑的药物及其制备方法 | |
| CN105456739A (zh) | 一种金钗石斛虫茶酒 | |
| CN104189585A (zh) | 治疗小儿癫痫的中药组合物及其制备方法 | |
| CN104547494A (zh) | 治疗甲亢的中药组合物药酒及制备工艺 | |
| CN103520643A (zh) | 一种用于治疗糖尿病白内障的中药制剂及其制备方法 | |
| CN103157003B (zh) | 一种具有保健作用的南瓜发酵药酒的制备方法、其产品及用途 | |
| CN105770760A (zh) | 主治胃溃疡的制剂及其制备方法 | |
| CN105795271A (zh) | 一种润胃排毒健康饮料及其制备方法 | |
| CN105797067A (zh) | 一种保护心脑血管的保健品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150826 Termination date: 20161114 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |